Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Exicure, Inc. (XCUR)

2.28   0.04 (1.79%) 08-18 05:54
Open: 2.24 Pre. Close: 2.24
High: 2.6899 Low: 2.2
Volume: 856,564 Market Cap: 11(M)
Exicure, Inc., a biotechnology company, develops therapies for neurological disorders and hair loss based on its proprietary spherical nucleic acid (SNA) technology. Its lead program candidate includes SCN9A that is in preclinical studies for neuropathic and chronic pain. The company has a collaboration, option, and license agreement with AbbVie Inc. to develop SNA-based treatments for hair loss disorders; and collaboration agreement with Ipsen S.A. to research, develop, and commercialize novel spherical nucleic acids for Huntington's disease and Angelman syndrome. Exicure, Inc. was founded in 2011 and is headquartered in Chicago, Illinois.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 2.69 - 2.7 2.7 - 2.72
Low: 2.17 - 2.18 2.18 - 2.2
Close: 2.26 - 2.28 2.28 - 2.3

Technical analysis

as of: 2022-08-17 4:27:52 PM
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 3     One year: 3.78
Support: Support1: 1.49    Support2: 1.23
Resistance: Resistance1: 2.57    Resistance2: 3.24
Pivot: 2.09
Moving Average: MA(5): 2.26     MA(20): 1.99
MA(100): 3.39     MA(250): 12.78
MACD: MACD(12,26): 0     Signal(9): -0.1
Stochastic oscillator: %K(14,3): 45.1     %D(3): 44.9
RSI: RSI(14): 52.3
52-week: High: 43.5  Low: 0.11
Average Vol(K): 3-Month: 839 (K)  10-Days: 1,710 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ XCUR ] has closed below upper band by 35.5%. Bollinger Bands are 51.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 21 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Mon, 15 Aug 2022
Exicure, Inc. Reports Second Quarter 2022 Financial Results and Corporate Progress - Yahoo Finance

Mon, 15 Aug 2022
Is Exicure Inc (XCUR) Stock About to Get Hot Monday? - InvestorsObserver

Sat, 13 Aug 2022
Exicure, Inc. (NASDAQ:XCUR) Short Interest Up 20.3% in July - Defense World

Mon, 08 Aug 2022
Is Exicure Inc (XCUR) Stock a Smart Value Monday? - InvestorsObserver

Thu, 04 Aug 2022
Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday - InvestorPlace

Fri, 29 Jul 2022
Short Interest in Exicure, Inc. (NASDAQ:XCUR) Decreases By 51.5% - Defense World

Financial Analysis

Price to Book Value: Neutral
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. 0 (M)
Shares Float 5 (M)
% Held by Insiders 2.89e+006 (%)
% Held by Institutions 27.5 (%)
Shares Short 141 (K)
Shares Short P.Month 0 (K)

Stock Financials

EPS -5.577e+007
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin (%) 0
Operating Margin (%) -5
Return on Assets (ttm) 247.1
Return on Equity (ttm) -54.9
Qtrly Rev. Growth 1.08e+006
Gross Profit (p.s.) 123.85
Sales Per Share -177.28
EBITDA (p.s.) -3.84567e+007
Qtrly Earnings Growth -0.7
Operating Cash Flow 0 (M)
Levered Free Cash Flow -33 (M)

Stock Valuations

PE Ratio -0.01
PEG Ratio 0
Price to Book value 0
Price to Sales -0.02
Price to Cash Flow 3.66

Stock Dividends

Dividend 0
Forward Dividend 117550
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.